A new #tuberculosis (TB) treatment combining #alpibectir and #ethionamide has shown promising results in patients.

Supported by #EDCTP-funded bEto-TB project.

🔗 Read the correspondence: www.nejm.org/doi/full/10....

#GlobalHealthEDCTP3Knowledge

Tale of potent anti-TB treatment highlights power of partnerships A promising and much-needed tuberculosis (TB) treatment is advancing through clinical trials thanks to support from European partnerships IMI2 and EDCTP.

A promising tuberculosis treatment is advancing through clinical trials thanks to support from European partnerships @ihieurope.bsky.social and #EDCTP.

#Alpibectir is a novel TB treatment that boosts the effectiveness of the decades-old drug ethionamide.

More 👇